Overview

A biopharma company was developing a number of combination drugs in oncology. RxC was asked to investigate combination treatment strategies to ensure commercial success.

Approach

RxC worked closely with the client team to:

• Conduct secondary and primary research to evaluate the key drivers of combination treatments, including dosing, route of administration, and delivery.

• Develop a market-based selection and evaluation framework for combination therapies using best practices.

• Review and refine a framework and decision tree to guide cross-functional product development teams.

Results

The client leveraged RxC's findings to further enhance the decision-making process regarding the selection and development of combination treatments in oncology.